The designation 4‑AcO‑MALT appears occasionally in informal discussions of novel psychoactive substances, particularly within online forums that focus on research chemicals and tryptamine derivatives. The term is not found in standard pharmacological textbooks, peer‑reviewed scientific literature, or major drug regulatory databases, and therefore lacks verification from reliable encyclopedic sources.
Etymology and Plausible Chemical Interpretation
- 4‑AcO – In the context of tryptamines, the prefix “4‑AcO” commonly denotes a 4‑acetoxy substitution on the indole ring, analogous to the structure of 4‑acetoxy‑N,N‑dimethyltryptamine (4‑AcO‑DMT).
- MALT – The suffix “MALT” has been used informally to refer to N‑methyl‑N‑allyl‑tryptamine, a compound in which the amine nitrogen bears a methyl group and an allyl group.
Combining these elements, 4‑AcO‑MALT would plausibly describe a molecule in which the indole nucleus of N‑methyl‑N‑allyl‑tryptamine carries a 4‑acetoxy functional group. However, without corroborating structural data, synthesis reports, or pharmacological studies, this interpretation remains speculative.
Current Status
- Recognition: The term is not listed in international drug control schedules, the United Nations Office on Drugs and Crime (UNODC) publications, the United States Controlled Substances Act, or the European Monitoring Centre for Drugs and Drug‑addiction (EMCDDA) reports.
- Scientific Documentation: No peer‑reviewed articles, clinical trial records, or reputable chemical registries (e.g., PubChem, ChemSpider, CAS) contain entries for “4‑AcO‑MALT.”
- Regulatory Perspective: Because of the lack of formal identification, regulatory agencies have not issued specific guidance or scheduling decisions concerning this compound.
Conclusion
Given the absence of verifiable information from authoritative sources, 4‑AcO‑MALT cannot be described as an established chemical entity within the scientific or regulatory literature. Any discussion of its properties, effects, or legal status remains unsubstantiated. Further research and formal documentation would be required to confirm its existence, structure, and pharmacology.